Infectious Disease

What Infectious Disease Attendings Actually Do Day-to-Day

The dominant mental image of an ID attending—rounding on complicated bacteremia cases and writing consult notes—is accurate for part of the job and misleading for the whole. What the practice actually looks like depends heavily on setting, but the breadth is wider than most IM residents appreciate before they start looking seriously.

Inpatient consultation is the visible core. Endocarditis workups, fever of unknown origin, fungal infections in immunocompromised patients, multidrug-resistant organism management, and postoperative wound infections constitute the daily volume at most academic centers. The consulting relationship means you rarely have primary ownership of a patient—you advise, you follow, and you sometimes have to persuade reluctant teams. That dynamic is either intellectually freeing or quietly frustrating depending on your personality.

Outpatient practice adds a second dimension that surprises many residents. HIV primary care is a substantial and growing panel at most academic ID practices. PrEP clinics, STI management, travel medicine, and post-COVID complication follow-up have expanded outpatient volume significantly over the past decade. Some ID physicians spend the majority of their clinical hours in clinic, not on the wards. Patients in HIV care in particular are often longitudinal relationships spanning decades—closer to primary care continuity than the episodic consult model.

Antimicrobial stewardship has become a distinct and formalized professional role. Joint Commission and CMS requirements have created dedicated stewardship programs at essentially all accredited hospitals (see the current CMS Conditions of Participation for specifics). Many ID physicians hold formal stewardship director titles with protected time, formulary authority, and administrative responsibilities. This is operational medicine: pharmacy partnerships, data dashboards, prescriber education, and policy writing. It is not everyone's preference, but it has created durable employment leverage for ID physicians that did not exist a generation ago.

At academic centers, research constitutes a substantial fraction of an ID attending's effort—sometimes the majority. Basic science investigation into host-pathogen interaction, clinical trials for antifungal agents or antiretrovirals, epidemiological modeling, and global health implementation science are all live career paths. ID has historically been one of the more NIH-grant-active subspecialties within internal medicine, partly because infectious pathophysiology lends itself to mechanistic investigation and partly because HIV research infrastructure created durable funding pipelines.

Subspecialty niches within ID include transplant infectious disease (solid organ and stem cell), pediatric ID (requiring separate fellowship training), travel and tropical medicine, clinical microbiology (with a separate board pathway), infection control and hospital epidemiology, and international/global health. These are not minor variations—a transplant ID specialist and a travel medicine physician occupy genuinely different professional worlds. The fellowship trains generalists; the niche develops during and after training through deliberate exposure.

The ID Fellow Personality Profile

Certain cognitive and temperamental features predict sustained satisfaction in ID more reliably than academic pedigree. Being honest about these before applying saves everyone time.

Comfort with diagnostic ambiguity. ID cases frequently lack clean resolution. A fever workup may end with a probable diagnosis and an empiric treatment trial rather than a confirmed pathogen. A patient with recurrent infections may never yield a clear immunodeficiency diagnosis. The physician who needs closure to feel competent will find this chronically destabilizing. The one who finds probabilistic reasoning intrinsically satisfying will find it energizing.

Detective-style pattern recognition across time. ID requires integrating exposure history, travel, animal contact, sexual history, immune status, microbiological data, and imaging across a timeline—often reconstructed retrospectively from a patient who is sick and disorganized in their recollection. This is not algorithmic work. It rewards curiosity about context, willingness to ask socially complex questions without judgment, and genuine interest in the epidemiological story behind a pathogen.

Tolerance for complex social histories. HIV care, injection drug use-associated infections, and STI management bring practitioners into frequent contact with patients navigating poverty, incarceration, housing instability, and stigma. ID physicians who practice in these areas describe it as one of the most meaningful parts of their work. Physicians who find this patient population draining rather than engaging will find large segments of the specialty difficult.

Genuine intellectual pleasure in microbiology and pharmacology. This is perhaps the most honest filter. ID requires sustained engagement with a knowledge base that is both wide and rapidly evolving—new resistance mechanisms, updated treatment guidelines, emerging pathogens. Physicians who enjoyed their micro and pharmacology rotations and read updates in these areas voluntarily are signaling something real. Physicians who found those rotations purely instrumental will find the reading load of ID practice burdensome rather than interesting.

Willingness to function as a consultant rather than a primary physician. Inpatient ID is structurally advisory. Your recommendations can be—and sometimes are—ignored. Your leverage is persuasion and relationship, not order-writing authority. This requires both confidence in your clinical reasoning and equanimity when teams go their own direction. Physicians who need direct control of clinical decision-making will find the consult structure persistently frustrating.

Core Competencies You'll Need Coming In

Fellowship programs expect arriving fellows to function as capable internists, not ID specialists—but certain knowledge domains accelerate your early months substantially.

Microbiology fundamentals. Gram stain interpretation, organism classification, basic understanding of culture techniques and sensitivity testing, and familiarity with major resistance mechanisms (ESBL, MRSA, CRE, VRE, azole resistance in fungi) are baseline. Programs will not teach you what a Gram-positive rod is. Fellows who arrive with solid micro groundwork from residency spend their early rotations refining clinical reasoning rather than rebuilding basic science scaffolding.

Antimicrobial pharmacology and pharmacokinetics. Mechanism of action, spectrum, major toxicities, and key drug interactions for the major antimicrobial classes should be working knowledge, not look-up knowledge, by the time you start fellowship. Vancomycin AUC monitoring, aminoglycoside dosing in renal failure, and beta-lactam pharmacodynamic principles come up in the first week. Residents who have worked with clinical pharmacists on stewardship or complex dosing during residency arrive with a meaningful advantage.

Immunology of host defense. Understanding how T-cell defects, neutropenia, complement deficiency, and humoral immune failure each produce characteristic vulnerability patterns allows you to anticipate organisms before culture data arrives. This is the mechanistic framework that separates pattern-matching from genuine ID reasoning.

Physical examination of infectious presentations. Skin findings in disseminated infections (petechiae, Janeway lesions, Osler nodes, ecthyma gangrenosum), funduscopic findings in endogenous endophthalmitis, joint examination in septic arthritis, and neurological examination in encephalitis are skills that must be functional. ID fellows are frequently called to examine findings that prompted the consult; arriving with polished examination skills creates immediate credibility.

Self-assessing gaps during residency. Pull your micro and pharmacology knowledge and compare it against a fellowship preparation resource such as IDSA's training guidelines or a board review text. Identify specific organism classes or drug categories where your knowledge is thin and build rotation-specific learning objectives around closing those gaps. Volunteering to staff ID consults as the primary IM resident and attending micro lab conferences are the two highest-yield gap-closing activities available in most programs.

Fellowship Training: What Two Years Actually Looks Like

ACGME accreditation requirements for ID fellowship specify minimum clinical and educational experiences; programs vary in how they sequence and supplement these. The following describes the typical structure at a program with genuine breadth—not every program offers every rotation.

Inpatient consult service. This is the core rotation and recurs throughout training. Fellows manage the consult list with graduated autonomy, staffed by an attending. Case complexity at academic centers is substantial: endocarditis requiring surgical decision-making, CNS infections, bone and joint infections, fever in returning travelers, and infections in solid organ transplant recipients. Volume teaches pattern recognition; feedback from attendings shapes reasoning style.

HIV clinic. Longitudinal outpatient care of people living with HIV. Antiretroviral management, opportunistic infection prophylaxis, comorbidity screening, and PrEP prescribing. Fellows at programs with large HIV panels develop genuine continuity relationships and see the full spectrum from new diagnosis to well-controlled chronic disease management. This rotation is where most fellows consolidate their outpatient ID identity.

Antimicrobial stewardship. Embedded time with the stewardship team, which at most programs means prospective audit and feedback on the wards, formulary restriction processes, and often a quality improvement project. This rotation exposes fellows to the operational and administrative dimensions of ID practice that purely clinical training misses.

Clinical microbiology laboratory. Direct time with the micro lab, including reading cultures, interpreting susceptibility reports, and understanding laboratory workflow. This rotation is intellectually dense and underappreciated by fellows until they start practicing—the attending who understands what the lab can and cannot do orders far more efficiently and interprets results more accurately.

Transplant ID. Infection management in solid organ transplant recipients is a subspecialty within a subspecialty. Immunosuppression titration in the context of infection, donor-derived infections, opportunistic pathogens in the transplant context, and post-transplant monitoring are the focus. Programs affiliated with active transplant programs offer this; programs without transplant surgery have limited exposure.

International/global health electives. Not universal, but available at programs with established partnerships. Typically structured as one to two months at an international site with endemic tropical or parasitic disease. For fellows with global health career interests, this rotation is formative. For fellows planning domestic practice, it is broadening but not essential.

Research time. Academic programs require a meaningful research component, often one block or more per year with the expectation of a project that generates a manuscript or abstract. This is where the academic-versus-community trajectory begins to diverge. Fellows who use research time productively emerge competitive for academic jobs; fellows who treat it as protected vacation emerge with a gap in their CV.

Call structure. ID fellowship call is generally less intense than IM residency call by volume, but the complexity of individual calls is high and the cognitive demand is not trivial. Most programs have home call or phone triage rather than in-house overnight. Fellow experience varies significantly by program—some programs offer robust overnight volume that accelerates independent decision-making; others have relatively quiet call with high attending involvement. This is worth asking about specifically during interviews.

Academic vs. Community ID: Two Very Different Careers

This is the most important self-sorting decision in ID career planning, and most residents make it too late or by default rather than deliberately.

Academic ID centers on subspecialty clinical expertise, research productivity, and teaching. The career typically requires a niche—transplant ID, HIV, clinical microbiology, global health, or a specific pathogen domain—because academic centers need specialists who can attract patients and funding, not generalists. Research effort is protected and expected; grants (NIH, foundation, industry) are the currency of academic survival. Teaching fellows, residents, and students is a formal part of the role. Compensation is lower than community practice, sometimes substantially, and academic advancement is contingent on publication and grant activity. The career rewards physicians who are genuinely driven by questions and comfortable with the slow, uncertain cadence of research.

Community ID is broader and more operationally immediate. Bread-and-butter infections—skin and soft tissue, pneumonia, urinary tract infections, wound infections, osteomyelitis—constitute the volume. Stewardship leadership, infection control committee work, and hospitalist-adjacent consultation are the institutional roles. Academic output is not expected and not rewarded in compensation. The career is clinically satisfying for physicians who prefer direct patient impact over hypothesis testing, and financially more straightforward in that compensation is driven by RVU generation and stewardship stipends rather than grant overhead. The tradeoff is less subspecialty depth and less access to the complex cases that come to tertiary centers.

The divergence begins during fellowship. Fellows who want academic careers should be building a research identity by the end of their first year—a mentor, a project, and a clear niche. Fellows planning community careers should prioritize breadth of clinical exposure and stewardship leadership experience. Most programs can accommodate both trajectories with deliberate planning; few programs optimize for both simultaneously without fellow agency.

A third trajectory that does not fit cleanly into either category: regional academic community hospital. These positions often combine academic affiliation (teaching, some research expectation) with community-level patient volume and compensation closer to community practice. They are increasingly common and worth considering explicitly for physicians who find neither pure pole fully satisfying.

Compensation, Job Market, and Financial Reality

This section addresses the financial picture in general terms. For current figures, consult the IDSA Annual Physician Compensation and Practice Survey (published annually), the AAMC Faculty Salary Report for academic positions, and MGMA compensation data for employed and private-practice models. Figures shift with market conditions and are not reproduced in prose here to avoid stale numbers.

The honest framing: ID has historically sat at the lower end of the IM subspecialty compensation range. This is a structural feature of the specialty—it is predominantly cognitive, non-procedural, and partially dependent on consultation volume rather than direct billing. Physicians carrying significant medical school debt into ID fellowship should model their financial trajectory explicitly, using current figures from the sources above, before committing to the specialty.

What has shifted the picture: Stewardship mandates from CMS and the Joint Commission have created formal, compensated administrative roles that did not exist a generation ago. Hospitals now have regulatory pressure to employ ID physicians in stewardship director positions, and those positions carry stipends or protected-time compensation that supplements clinical income. The net effect is that employed ID physicians at well-organized health systems often earn meaningfully more than the clinical billing figures alone would suggest.

HIV and PrEP volume growth has expanded outpatient billing and panel sizes at programs with established HIV practices. This is a genuine market driver in urban and suburban settings with high HIV prevalence and active PrEP prescribing communities.

Job market demand: IDSA workforce analyses have consistently identified ID physician shortages, particularly in community settings and rural areas. The match rate for ID fellowship positions and the unfilled program rate have both reflected a specialty with more positions available than competitive applicants in some recent cycles—see NRMP fellowship match data (available publicly at nrmp.org) for the most current cycle. This is an unusual labor market position for a subspecialty and has practical implications: ID fellows who perform reasonably well in training are likely to find multiple job offers, with geographic flexibility depending on setting preference.

What this means for career planning: If financial return per year of additional training is the primary variable in your decision, ID requires honest accounting. If the intellectual profile, job security, and breadth of practice are weighted alongside compensation, the picture is more favorable. Neither framing is wrong; the goal is to make the calculation deliberately rather than discovering the compensation reality at the end of fellowship.

Signs ID May Not Be the Right Fit

This section is written to help residents self-screen honestly, not to discourage. The goal is deliberate self-selection, not gatekeeping.

Experiences That Signal You'll Thrive

These are not requirements. They are patterns that, taken together, suggest a genuine fit rather than a constructed interest.

How Competitive Is ID Fellowship and Who Gets In

ID fellowship competitiveness has a structural feature that distinguishes it from most IM subspecialties: in recent NRMP match cycles, the specialty has had a meaningful rate of unfilled positions. Current data is available at nrmp.org under the fellowship match statistics; always check the most recent cycle rather than relying on summaries. The practical implication is that the applicant pool is not as compressed as cardiology or gastroenterology, and the margin of error in application is wider.

That said, the top academic programs—those with strong NIH-funded research infrastructure, high-complexity patient volumes, and established training reputations—are competitive in the conventional sense. Applicants targeting those programs need the same profile as any competitive IM subspecialty applicant: strong USMLE scores, research activity with presentations or publications, letters from ID faculty who know them substantively, and evidence of genuine engagement with the field.

What programs weight heavily:

Step scores: Competitive programs have score thresholds, though these are generally lower than cardiology or GI. Strong Step 1 and Step 2 CK scores help; they rarely compensate for absence of research or weak letters at top programs, and they rarely disqualify an otherwise strong applicant at community-based programs. IMGs should review NRMP data on IMG match rates for ID fellowship specifically; the fellowship match is distinct from the residency match in its IMG patterns.

Building Your Application During Residency

The timeline below assumes a three-year IM residency and fellowship application during PGY-3. Compress or adapt for two-year accelerated programs or preliminary intern years.

PGY-1: Establish the foundation. Identify one ID attending at your program whose work interests you and make contact before the end of intern year—not to ask for a letter immediately, but to introduce yourself and express interest. Attend any microbiology or stewardship educational sessions available. When you have ID consult patients on your service, engage substantively with the fellow and attending rather than passively receiving recommendations.

PGY-2: Build a project and deepen clinical exposure. The most common application weakness for ID fellowship is absence of any research or QI project. Identify a project by the middle of PGY-2—a stewardship QI initiative, a retrospective chart review, a case series—and commit to seeing it to a presentable stage. This does not require a published paper; an abstract submitted to IDSA or SHEA is a legitimate marker. Attend the IDSA annual meeting if financially feasible; the medical student and resident section has specific programming and networking opportunities. Request elective time on the ID consult service if your program offers it.

PGY-3: Finalize mentorship, letters, and personal statement. By the start of PGY-3, your primary ID letter writer should know your clinical work directly and should have been part of your project in some capacity. ERAS opens in the summer preceding fellowship start; letter requests should be made with adequate lead time. The personal statement should have a specific intellectual thread—identify it early and draft it before the rotation season competes for attention. Programs vary on the number of applications to submit; ID's less compressed market means strategic rather than exhaustive application is reasonable for most applicants.

IDSA membership and the trainee section. IDSA maintains a medical student and resident section with networking resources, mentorship programs, and fellowship guidance. Membership during residency is low cost and signals genuine engagement to letter writers and programs who notice it.

Questions to Ask Yourself Before Applying

Work through these before finalizing your decision. They are not hurdles—they are the kind of deliberate self-assessment that produces career satisfaction rather than career regret.

  1. When I encounter an ID consult case on my service, does my curiosity pull me toward the mechanism and the microbiological story, or do I primarily want the consult team to give me the answer so I can move on?
  2. Am I comfortable advising without primary ownership? Can I write a consult note knowing the team may not follow my recommendation and not find that persistently demoralizing?
  3. Do I genuinely enjoy reading about microbiology and antimicrobial pharmacology outside of required preparation? If so, is that interest durable across years or was it driven by a single rotation or mentor?
  4. How do I feel after encounters with patients navigating injection drug use, HIV, or housing instability? Do those encounters feel like important clinical work, or do they feel like a drain?
  5. Have I modeled the financial implications of ID fellowship—including loan repayment scenarios—using current compensation data, and is the outcome acceptable relative to alternatives?
  6. Am I drawn to the academic path, and if so, do I have a genuine research question or niche interest that could sustain a grant-funded career? Or am I assuming I want academic medicine because that is the default prestige pathway in my program?
  7. Am I drawn to community ID, and do I understand what that practice concretely looks like—the patient mix, the stewardship responsibilities, the call structure—rather than a vague idea of "less pressure"?
  8. Do I have at least one ID mentor who knows my clinical work and can speak to my genuine engagement with the field, not just my academic credentials?
  9. If I imagine myself in an ID attending role in ten years—seeing complex consults, managing HIV panels, doing stewardship rounds, possibly writing grants—does that image feel like arrival or like settling?
  10. Am I applying to ID because it is a genuine fit, or because my other subspecialty interests are more competitive and ID feels safer? If the latter, how confident am I that I will find sustained satisfaction in the work?
  11. What specifically about microbiology, epidemiology, or host-pathogen interaction has produced genuine intellectual pleasure in my training so far? Can I articulate it clearly? If not, why not?
  12. Am I prepared for the pace of ID—weeks-long antibiotic courses, chronic HIV management, prolonged diagnostic uncertainty—and does that pace align with what I want from clinical work?

How ID Compares to Adjacent Subspecialties

For residents who are genuinely undecided, a direct comparison with adjacent fields is more useful than general enthusiasm about any single specialty.

ID vs. Pulmonary/Critical Care. Pulm/CC offers procedural skills (bronchoscopy, thoracentesis), primary ownership of the sickest patients in the hospital, and ICU intensity. The cognitive overlap with ID is substantial—pneumonia, ventilator-associated infections, immunocompromised hosts, sepsis—but the relationship to the patient is primary rather than advisory. Pulm/CC compensation is higher and the lifestyle during critical care months is more demanding. Residents drawn to direct resuscitation and procedural mastery alongside diagnostic complexity should examine whether that pull is toward the intensity of critical care rather than specifically toward ID reasoning.

ID vs. Hematology/Oncology. Heme/onc shares the complex immunocompromised patient and the ambiguity of prognosis conversations. It is also a two-year fellowship with a substantial outpatient longitudinal practice. Procedural income (bone marrow biopsies) and oncology drug administration billing create a different compensation structure. Residents drawn to ID's HIV continuity care may find heme/onc's oncology relationships similarly satisfying; residents drawn to the microbiological puzzle will find less of that in heme/onc. The fields intersect most clearly in transplant and febrile neutropenia; physicians who find themselves interested specifically in that intersection should examine both specialties honestly before choosing one.

ID vs. Hospital Medicine. Hospitalists manage the diagnostic and management problems that ID consults on, but as primary physicians with direct ownership. For residents who are drawn to breadth, complexity, and team-based medicine but not specifically to the microbiological substrate of ID, hospital medicine may be a better fit than two years of fellowship. Hospitalists with stewardship interest can develop antimicrobial leadership roles without fellowship training at many institutions. The honest question: is the fellowship investment—in time, in deferred income, in training demands—worth it for the specific expertise ID provides? For physicians with genuine microbiology and epidemiology interest, the answer is typically yes. For physicians primarily drawn to complex inpatient medicine, the answer deserves more scrutiny.

What makes ID unique among these options: No other IM subspecialty touches every organ system as consistently. ID consultants are involved in neurological infections, cardiac infections, bone infections, intraabdominal infections, skin and soft tissue, and pulmonary disease in the same week. The breadth is real and is one of the most commonly cited satisfactions among practicing ID physicians. Global health pathways—research and clinical work in low-resource settings—are also far more accessible from an ID base than from most IM subspecialties. These are genuine differentiators, not marketing language.

Next Steps: Turning Interest Into a Plan

Concrete actions producible within the next week, regardless of what year of training you are in: